SCHEMBL1908242

SCHEMBL1908242

CN1CCc2cc(F)c(Cl)cc2CC1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 4/20 0.47
HTR2C P28335 4/20 0.47
HTR2B P41595 2/20 0.47
DRD2 P14416 7/20 0.46
DRD3 P35462 6/20 0.46
DRD1 P21728 5/20 0.46
DRD5 P21918 5/20 0.46
ADRA2A P08913 1/20 0.44
CYP2D6 P10635 1/20 0.44
ADRA2B P18089 1/20 0.44
ADRA2C P18825 1/20 0.44
ADRA1D P25100 1/20 0.44
ADRA1A P35348 1/20 0.44
ADRA1B P35368 1/20 0.44
HTR6 P50406 2/20 0.43
NPSR1 Q6W5P4 1/20 0.43
SIGMAR1 Q99720 1/20 0.41
MAOA P21397 2/20 0.40
MAOB P27338 2/20 0.40
SLC6A4 P31645 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1906400 0.84 DRD2 (0.53) HTR2AHTR2CDRD2DRD3DRD1
SCHEMBL2625795 0.79 HTR2A (0.55) HTR2AHTR2CHTR2BDRD2DRD3
SCHEMBL2201535 0.78 HTR2A (0.56) HTR2AHTR2CHTR2BDRD2DRD1
SCHEMBL30888613 0.78 HTR2A (0.42) HTR2AHTR2CHTR2BNPSR1SIGMAR1
SCHEMBL29991968 0.78 HTR2A (0.42) HTR2AHTR2CHTR2BSIGMAR1SLC6A4
SCHEMBL2202642 0.75 HTR2A (0.43) HTR2AHTR2CHTR2BDRD2DRD1
SCHEMBL20365097 0.74 HTR2A (0.58) HTR2AHTR2CHTR2BDRD2DRD3
SCHEMBL12705960 0.74 DRD2 (0.54) DRD2DRD3DRD1DRD5MAOA
SCHEMBL13672966 0.72 HTR2C (0.59) HTR2AHTR2CHTR2BDRD2DRD1
SCHEMBL21008386 0.72 HTR2A (0.56) HTR2AHTR2CHTR2BDRD2DRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2322162-A1 5HT2C receptor modulator compositions and methods of use Arena Pharmaceuticals, Inc. (US) 2011-05-18 EP disclosed